Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced that the European ...
Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果